Background: We previously demonstrated that mesenchymal stromal cell (MSC) may be transdifferentiated into neuron-like cells. MSC may also help attenuate cerebral oedema and hasten recovery following acute stroke. Furthermore, the blood-brain barrier is semipermeable in the acute stroke period which allows MSC to be administered intravenously.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Cytotherapy
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect